GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zentiva SA (BSE:SCD) » Definitions » ROCE %

Zentiva (BSE:SCD) ROCE % : 20.26% (As of Sep. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Zentiva ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Zentiva's annualized ROCE % for the quarter that ended in Sep. 2023 was 20.26%.


Zentiva ROCE % Historical Data

The historical data trend for Zentiva's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentiva ROCE % Chart

Zentiva Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.56 8.05 10.62 13.91 11.91

Zentiva Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.77 27.77 20.25 12.41 20.26

Zentiva ROCE % Calculation

Zentiva's annualized ROCE % for the fiscal year that ended in Dec. 2022 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2022 )  (A: Dec. 2021 )(A: Dec. 2022 )
=115.422/( ( (1049.606 - 141.572) + (1205.173 - 174.185) )/ 2 )
=115.422/( (908.034+1030.988)/ 2 )
=115.422/969.511
=11.91 %

Zentiva's ROCE % of for the quarter that ended in Sep. 2023 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Sep. 2023 )  (Q: Jun. 2023 )(Q: Sep. 2023 )
=228.3/( ( (1372.92 - 270.767) + (1358.753 - 206.725) )/ 2 )
=228.3/( ( 1102.153 + 1152.028 )/ 2 )
=228.3/1127.0905
=20.26 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2023) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zentiva  (BSE:SCD) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.


Zentiva ROCE % Related Terms

Thank you for viewing the detailed overview of Zentiva's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Zentiva (BSE:SCD) Business Description

Traded in Other Exchanges
N/A
Address
50, Theodor Pallady Boulevard, Sector 3, Bucharest, ROU, 032266
Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes 126 products for human use, such as solids (tablets, capsules, and pellets) and injectable solutions.

Zentiva (BSE:SCD) Headlines

From GuruFocus

LMP Capital and Income Fund Inc. Announces Change in Portfolio Managers

By Business Wire Business Wire 07-26-2022